FIELD: biotechnology.
SUBSTANCE: disclosed is a mixture of components with high molecular weight for use as an active principle with a neuroprotective and antioxidant effect, obtained from sugarcane wax, wherein it consists of fatty acids with the number of carbon atoms from 26 to 36 in the form of alkali or alkali-earth salts, primary aliphatic alcohols with number of carbon atoms from 24 to 34 and unsaturated αβ-aldehydes with more than 48 carbon atoms. Also disclosed are food pharmaceutical compositions which contain said mixture.
EFFECT: invention provides neuroprotective effects due to inhibition of neurological deficiency; the obtained mixture also has antioxidant action.
10 cl, 7 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF REDUCING DEMAGE TO NERVOUS CELLS | 2007 |
|
RU2464977C2 |
| COMPOUNDS AND PHARMACEUTIC COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES | 2012 |
|
RU2569302C2 |
| NEUROPROTECTIVE FOOD ADDITIVE | 2005 |
|
RU2389500C2 |
| STEROIDAL NITRONES FOR TREATMENT AND PREVENTION OF CEREBRAL STROKE OR ISCHEMIA, ALZHEIMER'S AND PARKINSON'S DISEASE AND AMYOTROPHIC LATERAL SCLEROSIS | 2014 |
|
RU2668514C2 |
| AGENT POSSESSING ANTIRADICAL, CEREBROPROTECTIVE AND ANTIISCHEMIC PROPERTIES | 2010 |
|
RU2445090C1 |
| METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF P2X7 RECEPTOR | 2005 |
|
RU2410430C2 |
| SUSPENSION FOR ORAL ADMINISTRATION WITH ANTI-ULCER AND CHEMOPROTECTIVE EFFECTS IN COLON CANCER AND METHOD OF ITS USE | 2020 |
|
RU2806636C1 |
| METHOD OF TREATING NEUROLOGICAL DISORDERS WITH CARDIAC GLYCOSIDES | 2011 |
|
RU2582223C2 |
| METHOD OF TREATING NEUROLOGICAL CONDITIONS WITH CARDIAC GLYCOSIDS | 2011 |
|
RU2674679C2 |
| INHIBITOR OF PRODUCTION OF OXYGEN REACTIVE FORMS FOR TREATMENT OF DISEASES ASSOCIATED WITH FREE OXYGEN RADICALS | 2016 |
|
RU2775597C2 |
